Desarrollo de Vacunas
National Institutes of Health
Bethesda, Estados UnidosPublicacións en colaboración con investigadores/as de National Institutes of Health (1)
1998
-
Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions
Journal of Clinical Investigation, Vol. 102, Núm. 6, pp. 1239-1248